Physician profile
Mark Toma
NPI 1598083024
$4,437.13
in general payments reported to CMS, 2019-2025
22 companies · $698 in 2025
The $698 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $295 · 2021: $505 · 2022: $820 · 2023: $907 · 2024: $391 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,995.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $954.81 | 2019-2022 | |
| Medtronic, INC. | $859.76 | 2022-2024 | Propel, Sinuva, Nuvent |
| Acclarent, INC | $481.58 | 2019-2024 | Acclarent Aera, Relieva Spinplus, Acclarent Navwire |
| Boston Scientific Corporation | $353.77 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Regeneron Healthcare Solutions, INC. | $289.19 | 2020-2025 | Dupixent |
| Stryker Corporation | $265.66 | 2019-2022 | |
| Inspire Medical Systems, INC. | $220.75 | 2023 | Inspire |
| Hologic Sales and Service, LLC | $183.67 | 2024-2025 | Coolseal Generator |
| Integra Lifesciences Corporation | $160.75 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Cochlear Americas | $129.69 | 2019-2022 | |
| Optinose US, INC. | $113.52 | 2019-2025 | |
| Baxter Healthcare | $92.40 | 2022 | |
| Aerin Medical INC. | $88.86 | 2019-2025 | |
| Alk-Abello, INC | $59.74 | 2019 | |
| Kaleo, INC. | $40.65 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $29.33 | 2023 | Ryaltris |
| Acera Surgical, INC. | $28.14 | 2025 | Restrata Wound Matrix |
| Xoran Technologies LLC | $21.20 | 2021 | |
| Precigen, INC. | $20.88 | 2025 | |
| Genzyme Corporation | $18.87 | 2019 | |
| Glaxosmithkline, LLC. | $12.78 | 2021 | |
| Checkpoint Surgical, INC | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Toma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.